Ye Tian

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Locally Advanced

Prostate Cancer

Radiation Therapy

Top Venues

Journal of immunology research

Cell death discovery

International journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Pei-Jing Li, Ming Chen, Ye Tian
T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study. PloS one 18 (3) (2023)
Pei-Jing Li, Ming Chen, Ye Tian
T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study. PloS one 18 (3) (2023)
Pei-Jing Li, Ming Chen, Ye Tian
T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study. PloS one 18 (3) (2023)
Pei-Jing Li, Ming Chen, Ye Tian
T1-2N1M0 nasopharyngeal carcinoma chemotherapy or not: A retrospective study. PloS one 18 (3) (2023)
Lu Jin, Wei Zhang, Ming-Yu Yao, Ye Tian, Bo-Xin Xue, Wei Tao
GNE-493 inhibits prostate cancer cell growth via Akt-mTOR-dependent and -independent mechanisms. Cell death discovery 8 (1) (2022)
Jing Hu, Qian Ji, Fei Chen, Xiaoqin Gong, Chuansheng Chen, Kaijun Zhang, Ye Hua, Jinlei Wang, Rongkun Li, Xu Wang, Chunhua Dai, Ye Tian
CXCR2 Is Essential for Radiation-Induced Intestinal Injury by Initiating Neutrophil Infiltration. Journal of immunology research 2022 (2022)
Wenjing Xu, Liwei Xie, Yingying Yang, Jiayu Xu, Shang Cai, Ye Tian
KAT5 Inhibitor NU9056 Suppresses Anaplastic Thyroid Carcinoma Progression through c-Myc/miR-202 Pathway. International journal of endocrinology 2022 (2022)